Climb Bio (CLYM) Stock Chart & Stock Price History $2.38 +0.19 (+8.68%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Climb Bio Stock Price Performance The Climb Bio (CLYM) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 32.22%. In the past month, the stock has increased 68.79%, reflecting recent market activity. As of the latest close, Climb Bio traded at $2.19 with a market cap of $148.39 million and volume of 640,116 shares. Receive CLYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Climb Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+25.26%1 Month Performance+68.79%3 Month Performance+98.33%Year-To-Date Performance+32.22% CLYM Stock Chart for Friday, August, 22, 2025 CLYM Chart by TradingView Climb Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$2.25$2.19-2.67%$2.28$2.14640,116 shs$148.39 million08/20/2025$2.02$2.25+11.39%$2.29$1.98872,186 shs$152.47 million08/19/2025$2.11$2.02-4.27%$2.26$2.01837,361 shs$136.88 million08/18/2025$1.90$2.11+11.05%$2.15$1.931.65 million shs$142.97 million08/15/2025$1.72$1.90+10.47%$1.93$1.731.15 million shs$128.74 million08/14/2025$1.63$1.72+5.52%$1.72$1.61396,253 shs$116.24 million08/13/2025$1.61$1.63+1.24%$1.69$1.60383,270 shs$110.15 million08/12/2025$1.65$1.61-2.42%$1.68$1.55482,528 shs$108.80 million08/11/2025$1.70$1.65-2.94%$1.72$1.64370,153 shs$111.51 million08/08/2025$1.68$1.70+1.19%$1.75$1.66260,047 shs$114.89 million Get the Latest News and Ratings for CLYM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Climb Bio and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$1.75$1.68-4.00%$1.76$1.65271,211 shs$113.53 million08/06/2025$1.74$1.75+0.57%$1.77$1.63685,709 shs$118.27 million08/05/2025$1.70$1.74+2.35%$1.85$1.681.27 million shs$117.59 million08/04/2025$1.45$1.70+17.24%$1.78$1.664.67 million shs$114.88 million08/01/2025$1.40$1.45+3.57%$1.46$1.36145,674 shs$97.99 million07/31/2025$1.52$1.40-7.89%$1.52$1.39163,605 shs$94.61 million07/30/2025$1.51$1.52+0.66%$1.57$1.5095,663 shs$102.72 million07/29/2025$1.60$1.51-5.63%$1.64$1.50249,070 shs$102.04 million07/28/2025$1.45$1.60+10.34%$1.65$1.46769,133 shs$108.13 million07/25/2025$1.48$1.45-2.03%$1.51$1.43114,963 shs$97.99 million07/24/2025$1.48$1.48$1.53$1.4097,970 shs$100.02 million07/23/2025$1.41$1.48+4.96%$1.48$1.3859,578 shs$100.01 million07/22/2025$1.41$1.41$1.44$1.3764,961 shs$95.29 million07/21/2025$1.51$1.41-6.62%$1.53$1.40220,622 shs$95.29 million Related Companies Prothena Stock Chart Compass Therapeutics Stock Chart Kamada Stock Chart Evolus Stock Chart Tectonic Therapeutic Stock Chart COMPASS Pathways Stock Chart PureTech Health Stock Chart Aquestive Therapeutics Stock Chart Replimune Group Stock Chart Zhengye Biotechnology Stock Chart Receive CLYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Climb Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLYM) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersOne tiny company just cracked Google’s $19B problemGoogle, Microsoft, IBM… every major AI player will be forced to secure massive amounts of this material just t...True Market Insiders | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Climb Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Climb Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access